Viking Therapeutics' oral weight-loss pill meets expectations in mid-stage study

Viking Therapeutics

19/08/2025 12:15

Aug 19 (Reuters) - Viking Therapeutics VKTX.O said on Tuesday its experimental  weight-loss pill helped patients with obesity lose nearly 12.2% of their body weight on average over 13 weeks in a mid-stage study.

Analysts ahead of the results had expected weight loss in the range of 10% to 15% on average and greater than the 8.2% seen in a small early-stage trial.

 (Reporting by Sriparna Roy and Siddhi Mahatole in Bengaluru; Editing by Sriraj Kalluvila)

 ((siddhi.mahatole@thomsonreuters.com;))